Literature DB >> 1430587

Tidal volume, breathing frequency, and oxygen consumption at different pressure support levels in the early stage of weaning in patients without chronic obstructive pulmonary disease.

C Hörmann1, M Baum, G Luz, C Putensen, G Putz.   

Abstract

The objective of this study was to evaluate the influence of different PSV levels on VT, F, VO2 in the early weaning phase of patients without chronic obstructive pulmonary disease. These parameters were tested for the predictive power for the success of the weaning. Patients on SIMV were studied during the first weaning attempt with PSV. Depending on their ventilatory support demands after 24 h they were divided into responders (patients breathing on CPAP) and nonresponders (patients being on a more invasive ventilatory mode). 14 ICU patients without pre-existing pulmonary disease being ventilated for at least 3 days entered the study. 2 of them could be studied a second time after failing the first weaning attempt. Beside the level of ventilatory support no other changes (drugs, nutrition) were allowed. VO2, VT, F were measured by a computer controlled, metabolic unit connected to the expiratory port of a Siemens Servo Ventilator. In addition, airway pressures, arterial pressure and heart rate were recorded. The measurements were performed at PSV of 5, 10 and 20 cmH2O. Arterial blood-gases were drawn at the end of each 60 min lasting PS period. Responders and nonresponders could be separated by the response of VO2, VT and F to a change in PS 10 to PS 20 cmH2O. Patients who significantly increased VT and significantly decreased F did not fulfil our weaning criteria. Our responders did not show a significant change in these two parameters, but a significant increase in VO2 at PS 20 cmH2O could be observed.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1430587     DOI: 10.1007/bf01709837

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  8 in total

1.  Cardiovascular, respiratory, and metabolic changes produced by pressure-supported ventilation in intensive care unit patients.

Authors:  A Fassoulaki; M Eforakopoulou
Journal:  Crit Care Med       Date:  1989-06       Impact factor: 7.598

2.  Effect of pressure support ventilation on breathing patterns and respiratory work.

Authors:  H Tokioka; S Saito; F Kosaka
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

3.  Inspiratory work of breathing during weaning from mechanical ventilation.

Authors:  F Lemaire
Journal:  Acta Anaesthesiol Belg       Date:  1988

4.  Extubation criteria after weaning from intermittent mandatory ventilation and continuous positive airway pressure.

Authors:  J Tahvanainen; M Salmenperä; P Nikki
Journal:  Crit Care Med       Date:  1983-09       Impact factor: 7.598

5.  Inspiratory pressure support prevents diaphragmatic fatigue during weaning from mechanical ventilation.

Authors:  L Brochard; A Harf; H Lorino; F Lemaire
Journal:  Am Rev Respir Dis       Date:  1989-02

6.  Respiratory function during pressure support ventilation.

Authors:  N R MacIntyre
Journal:  Chest       Date:  1986-05       Impact factor: 9.410

7.  [Indirect calorimetry in artificially respirated children. 2. A measuring procedure and its evaluation in a newly developed metabolism-lung model].

Authors:  M Semsroth
Journal:  Infusionsther Klin Ernahr       Date:  1985-12

8.  Oxygen cost of breathing in postoperative patients. Pressure support ventilation vs continuous positive airway pressure.

Authors:  J P Viale; G J Annat; Y M Bouffard; B X Delafosse; O M Bertrand; J P Motin
Journal:  Chest       Date:  1988-03       Impact factor: 9.410

  8 in total
  1 in total

1.  Oxygen cost of breathing for assisted spontaneous breathing modes: investigation into three states of pulmonary function.

Authors:  W Weyland; M Schuhmann; J Rathgeber; A Weyland; U Fritz; G Laier-Groeneveld; B Schorn; U Braun
Journal:  Intensive Care Med       Date:  1995-03       Impact factor: 17.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.